β-cell glucotoxicity
β levels
muscle IL
β-induced β-cell dysfunction
β-cell function
β-cells
blood IL
β-cell death
induced enhancement of IL
clinical anti-IL
interactive roles of IL
failure of pancreatic β-cell insulin secretory function
Innovative muscle-specific IL
hyperglycaemia
T2D patients
exercise therapy
following exercise
β drug treatment approaches
effect of physical exercise
insulin sensitivity
insulin secretory dysfunction
insulin resistance
poor insulin secretion
Experienced Researcher
huge variability
diabetes
type
transgenic mouse model expertise
beneficial effect
knockout mouse models
high blood glucose
human physiology expertise
Supervisor
host institution
doubles mortality
bedside approach
bench
interleukin
adaptations
phenomena
non-responder
objective
future
knowledge